SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-21-023935
Filing Date
2021-02-16
Accepted
2021-02-16 16:08:05
Documents
2
Group Members
JEREMY C. GREENREDMILE BIOPHARMA INVESTMENTS II, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tm215825d16_sc13g.htm SC 13G/A 88378
2 EXHIBIT 99.1 tm215825d16_ex99-1.htm EX-99.1 5646
  Complete submission text file 0001104659-21-023935.txt   95648
Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Subject) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91525 | Film No.: 21638254
SIC: 2834 Pharmaceutical Preparations